How is risk determined in Burkitt lymphoma/Burkitt-like lymphoma (BL/BLL)?

Updated: Dec 20, 2019
  • Author: Ali H Kanbar, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

Currently, most patients are treated following a risk-adapted approach. In this classification, patients are broadly divided into two groups: low risk and high risk.

Low-risk patients are those who have nonbulky disease (< 10 cm), early stage (I or II) disease, good performance status, and a normal lactate dehydrogenase (LDH) level. High-risk patients include all other patients.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!